LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "oncology" as a keyword



Photo by kellysikkema from unsplash

Effect of the Serious Illness Care Program in Outpatient Oncology: A Cluster Randomized Clinical Trial.

Sign Up to like & get
recommendations! Published in 2019 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2019.0077

Abstract: Importance High-quality conversations between clinicians and seriously ill patients about values and goals are associated with improved outcomes but occur infrequently. Objective To examine feasibility, acceptability, and effect of a communication quality-improvement intervention (Serious Illness… read more here.

Keywords: intervention; trial; anxiety; serious illness ... See more keywords
Photo by nci from unsplash

Effect of an Oncology Nurse-Led Primary Palliative Care Intervention on Patients With Advanced Cancer: The CONNECT Cluster Randomized Clinical Trial.

Sign Up to like & get
recommendations! Published in 2021 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2021.5185

Abstract: Importance Guidelines recommend early specialty palliative care for all patients with advanced cancer, but most patients lack access to such services. Objective To assess the effect of CONNECT (Care Management by Oncology Nurses to Address… read more here.

Keywords: intervention; trial; palliative care; primary palliative ... See more keywords
Photo from wikipedia

Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020

Sign Up to like & get
recommendations! Published in 2022 at "JAMA Internal Medicine"

DOI: 10.1001/jamainternmed.2022.4924

Abstract: This cross-sectional study estimates all US Food and Drug Administration anticancer approvals in recent years and evaluates if an association exists between their cost and efficacy. read more here.

Keywords: food drug; oncology; drug administration; drug ... See more keywords
Photo from wikipedia

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures

Sign Up to like & get
recommendations! Published in 2019 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2018.6847

Abstract: Key Points Question What are the morbidity and mortality of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) compared with other major oncologic surgical procedures? Findings In this cohort study of 1822 patients who received… read more here.

Keywords: risk; mortality; oncology; morbidity mortality ... See more keywords
Photo from wikipedia

Comparison of Long-term Survival Benefits in Trials of Immune Checkpoint Inhibitor vs Non–Immune Checkpoint Inhibitor Anticancer Agents Using ASCO Value Framework and ESMO Magnitude of Clinical Benefit Scale

Sign Up to like & get
recommendations! Published in 2019 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2019.6803

Abstract: Key Points Question How frequently do immune checkpoint inhibitor (ICI) agents vs non-ICI agents qualify for American Society of Clinical Oncology Value Framework version 2 (ASCO-VF v2) tail-of-the-curve bonuses or European Society of Medical Oncology… read more here.

Keywords: immune checkpoint; oncology; checkpoint inhibitor; long term ... See more keywords
Photo from wikipedia

Canadian Regulatory and Health Technology Assessment for Malignant Hematology and Oncology Indications Compared With the US Food and Drug Administration Accelerated Approval Program

Sign Up to like & get
recommendations! Published in 2021 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.20301

Abstract: This quality improvement study compares US Food and Drug Administration accelerated approvals with Canadian health and technology assessment approvals and timelines for malignant hematology and oncology treatments. read more here.

Keywords: hematology; drug administration; administration accelerated; food drug ... See more keywords
Photo by visuals from unsplash

Assessment of Discrimination, Bias, and Inclusion in a United States Hematology and Oncology Fellowship Program

Sign Up to like & get
recommendations! Published in 2021 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.33199

Abstract: Key Points Question What are the experiences of trainees with respect to discrimination, bias, and inclusion during hematology and oncology fellowship? Findings In this qualitative study of anonymous hotline interviews with 17 fellows, 100% of… read more here.

Keywords: inclusion; discrimination bias; hematology; hematology oncology ... See more keywords
Photo by mjessier from unsplash

Misleading Reporting (Spin) in Noninferiority Randomized Clinical Trials in Oncology With Statistically Not Significant Results

Sign Up to like & get
recommendations! Published in 2021 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.35765

Abstract: Key Points Question Is the interpretation and reporting of noninferiority trials with primary end point results that are not statistically significant correct, and what are the associated factors of misleading reporting? Findings This systematic review… read more here.

Keywords: statistically significant; misleading reporting; noninferiority randomized; randomized clinical ... See more keywords
Photo from wikipedia

Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.

Sign Up to like & get
recommendations! Published in 2021 at "JAMA network open"

DOI: 10.1001/jamanetworkopen.2021.39769

Abstract: Importance Black men have a 2-fold increased risk of dying from prostate cancer compared with White men. However, race-specific differences in response to initial treatment remain unknown. Objective To compare overall and treatment-specific outcomes of… read more here.

Keywords: oncology; white men; prostate cancer; black men ... See more keywords
Photo from wikipedia

Reporting of Physicians’ or Investigators’ Choice of Treatment in Oncology Randomized Clinical Trials

Sign Up to like & get
recommendations! Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2021.44770

Abstract: This cross-sectional study examines the prevalence of restricted choice of treatment in control groups among physicians and investigators conducting oncology randomized clinical trials (RCTs). read more here.

Keywords: oncology; clinical trials; choice treatment; randomized clinical ... See more keywords
Photo from wikipedia

Representation of Investigators by Gender Among Authors of Phase 3 Oncology Trials Worldwide

Sign Up to like & get
recommendations! Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.0031

Abstract: This cross-sectional study uses worldwide oncology trial data to examine the proportion of female investigators in each country and across all trials. read more here.

Keywords: oncology; representation investigators; among authors; investigators gender ... See more keywords